FDA Approved: MEKINIST — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved MEKINIST (trametinib) from the original application for the treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutations…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• MEKINIST (trametinib)

Snippet

ORIG AP for MEKINIST (TRAMETINIB)